Growth Metrics

Dna X (SONM) Total Non-Current Liabilities (2018 - 2025)

Dna X's Total Non-Current Liabilities history spans 8 years, with the latest figure at $50.5 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $50.5 million for Q4 2025, up 15.35% from a year ago — trailing twelve months through Dec 2025 was $50.5 million (up 15.35% YoY), and the annual figure for FY2025 was $50.5 million, up 15.35%.
  • Total Non-Current Liabilities for Q4 2025 was $50.5 million at Dna X, up from $39.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $50.5 million in Q4 2025 to a low of $20.1 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $30.2 million (2023), against an average of $30.7 million.
  • The sharpest move saw Total Non-Current Liabilities fell 29.33% in 2024, then soared 68.02% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $21.1 million in 2021, then soared by 53.02% to $32.2 million in 2022, then decreased by 0.2% to $32.1 million in 2023, then surged by 36.06% to $43.7 million in 2024, then rose by 15.35% to $50.5 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $50.5 million, $39.1 million, and $35.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.